Allergic Reaction Clinical Trial
— ADVENTUREOfficial title:
Analysis of ADVerse evENTs in Anesthesia Using ARtificial IntelligencE
NCT number | NCT05185479 |
Other study ID # | 8505 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 12, 2020 |
Est. completion date | November 12, 2021 |
Verified date | December 2023 |
Source | University Hospital, Strasbourg, France |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The interest of health databases in anesthesia is no longer to be demonstrated. The aim of this research was to develop a natural language processing approach to establish a classification of adverse events observed during the perioperative period and to facilitate their analysis: The main objective of the study was to identify what a "naïve" unsupervised model would discover based on Adverse Event (AE) descriptions. Our second goal was to identify apparently unrelated events whose combination could favor the occurrence of an AE
Status | Completed |
Enrollment | 9559 |
Est. completion date | November 12, 2021 |
Est. primary completion date | October 12, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year and older |
Eligibility | Inclusion Criteria: - Minors and adults having had an allergic reaction associated with care - Having had an adverse event reported by an anesthetist between January 01, 2009 and June 30, 2020 Exclusion Criteria: - Patient not meeting the inclusion criteria |
Country | Name | City | State |
---|---|---|---|
France | Service d'Anesthésie et Réanimation chirurgicale - CHU de Strasbourg - France | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Strasbourg, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Development of a natural language processing approach to establish a classification of adverse events observed during the perioperative period and to facilitate their analysis. | The aim of this research was to develop a natural language processing approach to establish a classification of adverse events observed during the perioperative period and to facilitate their analysis:
The main objective of the study was to identify what a "naïve" unsupervised model would discover based on Adverse Event (AE) descriptions. Our second goal was to identify apparently unrelated events whose combination could favor the occurrence of an AE |
Files analysed retrospectively from January 01, 2009 to June 30, 2020 will be examined] |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04058743 -
Nickel Sensitivity
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Active, not recruiting |
NCT05605795 -
Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
|
||
Recruiting |
NCT06065137 -
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
|
N/A | |
Completed |
NCT04510376 -
Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method
|
N/A | |
Recruiting |
NCT05185362 -
Epidemiology of Pecan Nut Allergy
|
||
Completed |
NCT03525496 -
Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast Agents
|
||
Completed |
NCT03489694 -
Repeatability and Reproducibility of Skin Test Endpoint Titration
|
||
Completed |
NCT03942692 -
What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
|
||
Enrolling by invitation |
NCT05670756 -
Preoperative Survey to Evaluate Patient Allergy
|
||
Recruiting |
NCT05462444 -
Development of Personalized Balanced Nutrition Concept Through an IT Platform
|
||
Not yet recruiting |
NCT05284253 -
Is There an Allergy to Pure Metallic Gold Microparticles?
|
N/A | |
Completed |
NCT03157505 -
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
|
Phase 3 | |
Completed |
NCT01436617 -
Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab
|
Phase 2 | |
Not yet recruiting |
NCT05532566 -
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
|
N/A | |
Not yet recruiting |
NCT05533385 -
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.
|
N/A | |
Recruiting |
NCT06011603 -
Prineo Sensitivity Dressing Study
|
Phase 4 | |
Completed |
NCT04761822 -
COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
|
Phase 2 | |
Recruiting |
NCT05367531 -
Assessment of Injectable Medication Platforms
|
N/A |